Reumatología LUMINA, una Cohorte de Pacientes con Lupus en Minorías Étnicas de Estados Unidos. ¿Qué Hemos Aprendido?
Referencias
Reveille JD,
Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J et al. Systemic
lupus erythematosus in three ethnic groups: I. The effects of HLA class II,
C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset.
Arthritis Rheum. 1998;41:1161-72..
Alarcón
GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM et al.
Systemic lupus erythematosus in three ethnic groups: III. A comparison of
characteristics early in the natural history of the LUMINA cohort. Lupus.
1999;8:197-209.
Alarcón
GS, Roseman JM, Bartolucci AA, Friedman AW, Moulds JM, Goel N et al.
Systemic lupus erythematosus in three ethnic groups: II. Features predictive
of disease activity early in its course. Arthritis Rheum. 1998;41:1173-80.
Alarcón
GS, Rodríguez JL, Benavides G, Brooks K, Kurusz H, Reveille JD.
Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health-related
attitudes and behaviors and disease activity in Hispanic patients from the
LUMINA cohort. Arthritis Care Res. 1999;12:267-74.
Mikuls
TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ et al.
Mortality risk associated with rheumatoid arthritis in a prospective cohort
of older women: results from the Iowa Women's Health Study. Ann Rheum Dis.
2002;61:994-99.
Alarcón
GS, McGwin G, Jr., Roseman JM, Uribe A, Fessler B, Bastian HM et al.
Systemic lupus erythematosus in three ethnic groups. XIX: The natural history
of the accrual of the American College of Rheumatology Criteria prior to
the occurrence of criteria diagnosis. Arthritis Rheum (Arthritis Care Res).
2003;In Press.
Vilá
LM, Alarcón GS, McGwin GJr, Friedman AW, Baethge BA, Bastian HM et
al. Early clinical manifestations, disease activity and damage
of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
Rheumatology. 2004;43:358-63.
Krupp
LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity
Scale: application to patients with multiple sclerosis and systemic lupus
erythematosus. Arch Neurol. 1989;46:1121-23.
Friedman
AW, Tew MB, Ahn C, McGwin G, Jr., Fessler BJ, Bastian HM et al.
Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and
correlates of fibromyalgia. Lupus. 2003;12:274-79.
Cohen S, Mermelstein
R, Kamarch T, Hoberman HN. Measuring the functional components of
social support. In: Sarason IG, Sarason BR, eds. Social Support: Theory, Research
and Applications. Boston: Martinus Nijhoff; 1985: 73-94.
Pilowsky
I. Dimensions of illness behavior as measured by the illness behavior
questionnaire: A replication study. J Psychosom Res. 1993;37:53-62.
Engle EW, Callahan LF, Pincus T, Hochberg MC. Learned helplessness
in systemic lupus erythematosus: Analysis using the rheumatology attitudes
index. Arthritis Rheum. 1990;33:281-86.
Nicassio PM,
Wallston KA, Callahan LF, Herbert M, Pincus T. The measurement of
helplessness in rheumatoid arthritis. The development of the Arthritis Helplessness
Index. J Rheumatol. 1985;12:462-67.
. Zonana-Nacach
A, Roseman JM, McGwin G, Jr., Friedman AW, Baethge BA, Reveille JD et al.
Systemic lupus erythematosus in three ethnic groups, VI: Factors associated
with fatigue within 5 years of criteria diagnosis. Lupus. 2000;9:101-9.
Vilá
LM, Alarcón GS, McGwin GJr, Baethge BA, Reveille JD. HLA-Class
II alleles among two distinct U.S. Hispanic populations with systemic lupus
erythematosus. Arthritis Rheum. 2003;48:S574.
Liang MH, Socher
SA, Larson MG, Schur PH. Reliability and validity of six systems
for the clinical assessment of disease activity in systemic lupus erythematosus.
Arthritis Rheum. 1989;32:1107-18.
Gladman
DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D et al. Sensitivity
to change of 3 systemic lupus erythematosus disease activity indices: International
validation. J Rheumatol. 1994;21:1468-71.
Alarcón
GS, McGwin G, Jr., Brooks K, Roseman JM, Fessler BJ, Sanchez ML et al. Systemic
lupus erythematosus in three ethnic groups: XI. Sources of discrepancy in
perception of disease activity: A comparison of physician and patient visual
analog scale scores. Arthritis Rheum (Arthritis Care Res). 2002;47:408-13.
Alarcón
GS, McGwin G, Jr., Sanchez ML, Bastian HM, Fessler BJ, Friedman AW et al.
Systemic lupus erythematosus in three ethnic groups. XIV. Poverty,
wealth, and their influence on disease activity. Arthritis Rheum (Arthritis
Care Res). 2004;51:73-77.
Calvo-Alén
J, Uribe A, McGwin G, Reveille J, Alarcón GS. Persistently
active disease early in the course in systemic lupus erythematosus is associated
with sociodemographic factors and portends a poor prognosis (damage accrual).
7th International Lupus Conference, New York. 2004;Abstract.
Gladman DD, Gizzler
E, Goldsmith C, et al. The development and initial validation of
the systemic lupus international collaborating clinics/American College of
Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum.
1996;39:363-69.
Alarcón
GS, McGwin G, Jr., Bartolucci AA, Roseman J, Lisse J, Fessler BJ et al.
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage
accrual. Arthritis Rheum. 2001;44:2797-806.
Costenbader
KH, Mandl LA, Liang MH. Improving the utility of ACR criteria for
clinical trials. Lupus. 2001;10:S117.
Alarcón
GS, McGwin G, Jr., Bastian HM, Fessler BJ, Baethge BA, Friedman AW et al.
Systemic lupus erythematosus in three ethnic groups XIII: The "weighted"
criteria as predictors of damage. Lupus. 2002;11:329-31.
Alarcón
GS, Roseman JM, McGwin G, Jr., Uribe A, Bastian HM, Fessler BJ et al.
Systemic lupus erythematosus in three ethnic groups: XX. Damage as predictor
of further damage. Rheumatology. 2004;43:349-52.
Toloza S, Roseman
J, Alarcón GS, McGwin G, Uribe A, Fessler BJ et al. Systemic
lupus erythematosus in a multiethnic US cohort (LUMINA). Predictors of time
to the occurrence of initial damage. 7th International Lupus Conference, New
York. 2004;Abstract.
Fessler BJ, McGwin
G, Jr., Roseman JM, Bastian HM, Friedman AW, Baethge BA et al. Hydroxychloroquine
(HCQ) usage is associated with decreased renal and cardiovascular damage in
patients with systemic lupus erythematosus (SLE). Arthritis Rheum. 2001;44:S201.
Bastian HM, Roseman
JM, McGwin G, Jr., Alarcón GS, Friedman AW, Fessler BJ et al. Systemic
lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis
after diagnosis. Lupus. 2002;11:152-60.
Bastian
HM, Roseman J, Agee B, Kimberly R, Edberg J, Fessler B et al. Ethnicity
and non-renal disease activity are predictive of worsening proteinuria in
systemic lupus erythematosus patients. Arthritis Rheum. 2003;48:S578.
Zuniga
R, Ng S, Reveille JD, Baethge B, Lisse J, Alarcón GS et al.
Independent contribution to the risk of nephritis by allelic variants of
FctRIIa in Hispanic patients with systemic lupus erythematosus. Arthritis
Rheum. 2001;44:361-67.
Ho KT, Reveille
JD, Baethge BA, Tan FK, Friedman AW, Roseman J et al. The use of
hydroxychloroquine in the prevention of thrombosis in systemic lupus erythematosus.
Arthritis Rheum. 2003;48:S375.
Toloza SM, Uribe
A, McGwin G, Alarcón GS, Fessler B, Bastian HM et al. Systemic
lupus erythematosus in a multiethnic US cohort (LUMINA). Baseline predictores
of vascular events. 7th International Congress on SLE and Related Conditions,
New York. 2004;May:M32B.
Alarcón
GS, McGwin G, Jr., Bastian HM, Roseman JM, Lisse J, Fessler BJ et al.
Systemic lupus erythematosus in three ethnic group VII: Predictors of early
mortality in the LUMINA cohort. Arthritis Rheum (Arthritis Care Res). 2001;45:191-202.
Ware
JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36).
I. Conceptual frame work and item selection. Med Care. 1992;31:247-63.
Ware
JE, Kosinski M, Keller SD. SF-36 physical and mental health summary
scales: A user's manual. Boston:The Health Institute, New England Medical
Center. 1994.
Friedman AW,
Alarcón GS, McGwin G, Jr., Straaton KV, Roseman J, Goel N et al. Systemic
lupus erythematosus in three ethnic groups: IV. Factors associated with self-reported
functional outcome in a large cohort study. Arthritis Care Res. 1999;12:256-66.
Alarcón
GS, McGwin GJr, Uribe A, Friedman AW, Roseman JM, Fessler BJ et al. Systemic
lupus erythematosus in a multiethnic lupus cohort (LUMINA), XVII: Predictors
of self-reported health-related quality of life early in the disease course.
Arthritis Rheum (Arthritis Care Res). 2004;51:In Press.
Pincus T, Swearingen
C, Callahan LF. A self-report cognitive symptoms inventory to assess
patients with rheumatic diseases: Results in eosinophilia-myalgia syndrome
(EMS), fibromyalgia, rheumatoid arthritis (RA), and other rheumatic diseases.
Arthritis Rheum. 1996;39:S261.
Alarcón
GS, Cianfrini L, Bradley LA, Sanchez ML, Brooks K, Friedman AW et al.
Systemic lupus erythematosus in three ethnic groups: X. Measuring cognitive
impairment with the Cognitive Symptoms Inventory. Arthritis Rheum (Arthritis
Care Res). 2002;47:310-319.
Lorig K, Chastian
RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale
to measure perceived self- efficacy in people with arthritis. Arthritis Rheum.
1989;32:37-44.
Reveille JD,
Beasley TM, Tan FK, Roseman JM, Vilá LM, Bastian HM et al.
Admixture as a measure of genomic control. Data from a multiethnic lupus cohort.
Arthritis Rheum. 2003;48:S225.
Rubin
DB. Estimating causal effects from large data sets using propensity
scores. Ann Intern Med. 1997;127:757-63.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
